The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
-
Published:2024-02
Issue:2
Volume:5
Page:100637
-
ISSN:2666-3643
-
Container-title:JTO Clinical and Research Reports
-
language:en
-
Short-container-title:JTO Clinical and Research Reports
Author:
Patil TejasORCID,
Staley Alyse,
Nie Yunan,
Sakamoto Mandy,
Stalker Margaret,
Jurica James M.,
Koehler Kenna,
Cass Amanda,
Kuykendall Halle,
Schmitt Emily,
Filar Emma,
Reventaite Evelina,
Davies Kurt D.,
Nijmeh Hala,
Haag Mary,
Yoder Benjamin A.,
Bunn Paul A.,
Schenk Erin L.,
Aisner Dara L.,
Iams Wade T.,
Marmarelis Melina E.,
Camidge D. Ross
Funder
LUNGevity Foundation